4/24
07:05 am
rgnx
REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Low
Report
REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
4/17
07:29 am
rgnx
REGENXBIO Inc.'s (NASDAQ:RGNX) recent 7.9% pullback adds to one-year year losses, institutional owners may take drastic measures [Yahoo! Finance]
Low
Report
REGENXBIO Inc.'s (NASDAQ:RGNX) recent 7.9% pullback adds to one-year year losses, institutional owners may take drastic measures [Yahoo! Finance]
4/12
12:11 pm
rgnx
REGENXBIO Inc. (NASDAQ: RGNX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $40.00 price target on the stock.
Medium
Report
REGENXBIO Inc. (NASDAQ: RGNX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $40.00 price target on the stock.
4/11
02:04 am
rgnx
REGENXBIO Inc. (NASDAQ: RGNX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
REGENXBIO Inc. (NASDAQ: RGNX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
4/3
02:04 am
rgnx
REGENXBIO Inc. (NASDAQ: RGNX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
REGENXBIO Inc. (NASDAQ: RGNX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/28
01:30 pm
rgnx
REGENXBIO Sees Positive Results For Macular Degeneration Therapy [Yahoo! Finance]
Low
Report
REGENXBIO Sees Positive Results For Macular Degeneration Therapy [Yahoo! Finance]
3/28
07:21 am
rgnx
REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD [Yahoo! Finance]
Medium
Report
REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD [Yahoo! Finance]
3/28
07:05 am
rgnx
REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD
Medium
Report
REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD
2/27/2024
04:05 pm
rgnx
regenxbio inc.
MISS
Report
-0.5%
regenxbio inc.
11/8/2023
04:05 pm
rgnx
regenxbio inc.
BEAT
Report
2.4%
regenxbio inc.
8/2/2023
04:05 pm
rgnx
regenxbio inc.
MISS
Report
-7.5%
regenxbio inc.
5/3/2023
04:05 pm
rgnx
regenxbio inc.
MISS
Report
-1.6%
regenxbio inc.
4/17
05:05 pm
rgnx
Form 4 REGENXBIO Inc. For: Apr 15 Filed by: Mills Kenneth T.
Medium
Report
Form 4 REGENXBIO Inc. For: Apr 15 Filed by: Mills Kenneth T.
4/4
04:21 pm
rgnx
Form ARS REGENXBIO Inc. For: Dec 31
Low
Report
Form ARS REGENXBIO Inc. For: Dec 31
4/4
04:16 pm
rgnx
Form DEFA14A REGENXBIO Inc.
Low
Report
Form DEFA14A REGENXBIO Inc.
4/4
04:11 pm
rgnx
Form DEF 14A REGENXBIO Inc. For: May 31
Low
Report
Form DEF 14A REGENXBIO Inc. For: May 31
3/21
05:21 pm
rgnx
Form 4 REGENXBIO Inc. For: Mar 19 Filed by: Vasista Vittal
Medium
Report
Form 4 REGENXBIO Inc. For: Mar 19 Filed by: Vasista Vittal
3/18
05:04 pm
rgnx
Form 4 REGENXBIO Inc. For: Mar 14 Filed by: Mills Kenneth T.
Low
Report
Form 4 REGENXBIO Inc. For: Mar 14 Filed by: Mills Kenneth T.
3/11
08:01 am
rgnx
Form 8-K REGENXBIO Inc. For: Mar 06
Low
Report
Form 8-K REGENXBIO Inc. For: Mar 06
3/8
06:10 am
rgnx
Form 424B5 REGENXBIO Inc.
Medium
Report
Form 424B5 REGENXBIO Inc.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register